Derangement of hypothetical proteins in fetal down's syndrome brain

Neurochemical Research

Volumn 29, Issue 6, 2004, Pages 1307-1316

  Shin, Joo Ho ^a   Gulesserian, Talin ^a   Weitzdoerfer, Rachel ^a   Fountoulakis, Michael ^b   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Center for Medical Genomics   (Switzerland)

Author keywords

Down's syndrome; Fetal brain; Hypothetical protein; Predicted protein; Two dimensional gel electrophoresis

Indexed keywords

ACTIN RELATED PROTEIN; ACTIN RELATED PROTEIN 3; ADENOSINE TRIPHOSPHATASE; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN 90; NERVE PROTEIN;

BRAIN CORTEX; CHROMOSOME 21; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOSKELETON; DESORPTION; DOWN SYNDROME; FEMALE; FETUS; GENE OVEREXPRESSION; HUMAN; IONIZATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVIEW; TWO DIMENSIONAL ELECTROPHORESIS; ARTICLE; COMPARATIVE STUDY; GENETICS; GESTATIONAL AGE; INDUCED ABORTION; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; PATHOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; PROTEIN DATABASE; REFERENCE VALUE; SPONTANEOUS ABORTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ABORTION, INDUCED; ABORTION, SPONTANEOUS; DATABASES, PROTEIN; DOWN SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FETUS; GESTATIONAL AGE; HUMANS; MALE; NERVE TISSUE PROTEINS; PREGNANCY; REFERENCE VALUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 3142746639     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000023617.49590.19     Document Type: Review

References (49)

1. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
2. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., et al. 2001. The sequence of the human genome. Science 291:1304-1351.
3. Devos, D. and Valencia, A. Practical limits of function prediction. 2000. Proteins 41:98-107.
4. Todd, A. E., Orengo, C. A., and Thornton, J. M. 2001. Evolution of function in protein superfamilies, from a structural perspective. J. Mol. Biol. 307:1113-1143.
5. Brenner, S. E. 1999. Errors in genome annotation. Trends Genet. 15:132-133.
6. Zarembinski, T. I., Hong, L-W., Mueller-Dieckmann, H-J., Kim, K-K., Yokota, H., and Kim, R. 1998. Structure-based assignment of the biochemical function of a hypothetical protein: A test case of structure genomics. Proc. Natl. Acad. Sci. USA 95:15189-15193.
7. Epstein, C. J. 1995. Down syndrom - the metabolic and molecular bases of inherited disease. Pages 749-794, in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds.), McGraw Hill, New York.
8. Becker, L., Mito, E., Takashima, S., and Onodera, K. 1991. Growth and development of the brain in Down syndrome. Prog. Clin. Biol. Res. 373:133-152.
9. Wisniewski, K. E. 1990. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am. J. Med. Genet. 7(Suppl):274-281.
10. Hattori, M., Fujiyama, A., Taylor, T. D., Watanabe, H., Yada, T., Park, H-S., et al. 2000. The DNA sequence of human chromosome 21. Nature 405:311-319.
11. Kapranov, P., Cawley, S. E., Drenkow, J., Bekiranov, S., Strausberg, R. L., Fodor, S. P., and Gingeras, T. R. 2002. Large-scale transcriptional activity in chromosomes 21 and 22. Science 296:916-919.
12. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biophysics 344:125-132.
13. Weitzdoerfer, R., Fountoulakis, M., and Lubec, G. 2002. Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain. Biochem. Biophys. Res. Commun. 293:836-841.
14. Fountoulakis, M. and Langen, H. 1997. Identification of proteins by matrix assisted laser desorption ionization mass spectrometry following in-gel digestion in low salt, non-volatile buffer and simplified peptide recovery. Anal. Biochem. 250:153-156.
15. Berndt, P., Hobohm, U., and Langen, H. 1999. Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20:3521-3526.
16. Makarova, K. S., Aravind, S., and Koonin, E. V. 2000. A novel superfamily of predicted cysteine protease from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem. Sci. 25:50-52.
17. Sevier, C. S. and Machamer, C. E. 2001. p38: a novel protein that associates with the vesicular stomatitis virus glycoprotein. Biochem. Biophys. Res. Commun. 287:574-582.
18. Engidawork, E., Gulesserian, T., Fountoulakis, M., and Lubec, G. 2003. Expression of hypothetical protein in human fetal brain: increased expression of hypothetical protein 28.5 kDa in Down syndrome, a clue for its tentative role. Mol. Genet. Metab. 78:295-301.
19. Jay, P., Berge-Lefranc, T-L., Massacrier, A., Roessler, E., Wallis, D., Muenke, M., Gastaldi, M., Taviaux, S., Cau, P., and Berta, P. 2000. ARP3β, the gene encoding a new human actin-related protein, is alternatively spliced and predominantly expressed in brain neuronal cells. Eur. J. Biochem. 267:2921-2928.
20. Takahashi, N., Takahashi, Y., and Putnam, F. W. 1985. Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc. Natl. Acad. Sci. USA 82:1906-1910.
21. Kobe, B. and Deisenhofer, J. 1994. The leucine-rich repeat: a versatile binding motif. J. Trends. Biochem. Sci. 19:415-421.
22. Buchanan, S. G. and Gay, N. J. 1996. Structural and functional diversity in the leucine-rich repeat family of proteins. Prog. Biophys. Mol. Biol. 65:1-14.
23. Liu, Y. T. and Yin, H. L. 1998. Identification of the binding partners for flightless I, a novel protein bridging the leucine-rich repeat and the gelsolin superfamilies. J. Biol. Chem. 273:7920-2927.
24. Kobe, B. and Kajava, A. V. 2001. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11:725-732.
25. Francklyn, C., Perona, J. J., Puetz, J., and Hou, Y-M. 2002. Aminoacyl-tRNA synthetases: Versatile players in the changing theater of translation. RNA 8:1363-1372.
26. Ibba, M. and Soll, D. 2000. Aminoacyl-tRNA synthesis. Annu. Rev. Biochem. 69:617-650.
27. Mirande, M. 1991. Aminoacyl-tRNA synthetase family from prokaryotes and eukaryotes: structural domains and their implications. Prog. Nucleic Acid Res. Mol. Biol. 40:95-142.
28. Schimmel, P. 1987. Aminoacyl tRNA synthetases: general scheme of structure-function relationships in the polypeptides and recognition of transfer RNAs. Annu. Rev. Biochem. 56:125-158.
29. Mosyak, L., Reshetnikova, L., Goldgur, Y., Delarue, M., and Safro, M. 1995. Structure of phenylalanyl-tRNA synthetase from Thermus thermophilus. Nat. Struct. Biol. 2:537-547.
30. Schmucker, D., Clemens, J. C., Shu, H., Worby, C. A., Xiao, J., Muda, M., Dixon, J. E., and Zipursky, S. L. 2000. Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity. Cell 101:671-684.
31. Genschik, P., Billy, E., Swianiewicz, M., and Filipowicz, W. 1997. The human RNA 3′-terminal phosphate cyclase is a member of a new family of proteins conserved in Eucarya, Bacteria and Archaea. EMBO J. 16:2955-2967.
32. Kim, S. H., Dierssen, M., Ferreres, J. C., Fountoulakis, M., and Lubec, G. 2001. Increased protein levels of heterogenous nuclear ribonucleoprotein A2/B1 in fetal Down syndrome brains. J. Neural. Transm. (Suppl) 61:273-280.
33. Jakubowski, H., and Goldman, E. 1992. Editing of errors in selection of amino acids for protein synthesis. Microbiol. Rev. 56:412-129.
34. Ribas de Pouplana, L., and Schimmel, P. 2001. Formation of two classes of tRNA synthetases in relation to editing functions and genetic code. Cold Spring Harbor Symp. Quant. Biol. 66:131-166.
35. Beebe, K., Ribas de Pouplana, L., and Schimmel, P. 2003. Elucidation of tRNA-dependent editing by a class II tRNA synthetase and significance for cell viability. EMBO J. 22:668-675.
36. Johnson, J. L., Beito, T. G., Krco, C. J., and Toft, D. O. 1994. Characterization of a novel 23-kilodalton protein of unactive progesterone receptor complexes. Mol. Cell. Biol. 14:1956-1963.
37. Johnson, J. L. and Toft, D. O. 1995. Binding of p23 and hsp90 during assembly with the progesterone receptor. Mol. Endocrinol. 9:670-678.
38. Johnson, J., Corbisier, R., Stensgard, B., and Toft, D. O. 1996. The involvement of p23, hsp90, and immunophilins in the assembly of progesterone receptor complexes. J. Steroid. Biochem. Mol. Biol. 56:31-37.
39. Auluck, P. K., Chan, H. Y., Trojanowski, J. Q., Lee, V. M., and Bonini, N. M. 2002. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295:865-868.
40. Carmichael, J., Chatellier, J., Woolfson, A., Milstein, C., Fersht, A. R., and Rubinsztein, D. C. 2000. Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 97:9701-9705.
41. Dou, F., Netzer, W. J., Tanemura, K., Li, F., Hartl, F. U., Takashima, A., Gouras, G. K., Greengard, P., and Xu, H. 2003. Chaperone increase association of tau protein with microtubles. Proc. Natl. Acad. Sci. USA 100:721-726.
42. Yoo, B. C., Vlkolinsky, R., Engidawork, E., Cairns, N., Fountoulakis, M., and Lubec, G. 2001. Differential expression of molecular chaperones in brain of patients with Down syndrome. Electrophoresis 22:1233-1241.
43. Schuller, E., Gulesserian, T., Seidl, R., Cairns, N., and Lubec, G. 2001. Brain t-complex polypeptide (TCP-1) related to its natural substrate beta 1 tublin is decreased in Alzheimer's disease. Life Sci. 69:263-270.
44. Rohatgi, R., Ma, L., Miki, H., Lopez, M., Kirchhausen, T., Takenawa, T., and Kirschner, M. W. 1999. The interaction N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 97:221-231.
45. Gulesserian, T., Kim, S. H., Fountoulakis, M., and Lubec, G. 2002. Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal Down syndrome brain. Biochem. Biophys. Res. Commun. 291:62-67.
46. Lubec, B., Weitzdoerfer, R., and Fountoulakis, M. 2001. Manifold reduction of moesin in fetal Down syndrome brain. Biochem. Biophys. Res. Commun. 286:1191-1194.
47. Sprang, S. R. 1997. G protein mechanisms: Insights from structural analysis. Annu. Rev. Biochem. 66:639-678.
48. Sikora-Borgula, A., Slominska, M., Trzonkowski, P., Zielke, R., Mysliwski, A., Wegrzyn, G., and Czyz, A. 2002. A role for the common GTP-binding protein in coupling of chromosome replication to cell growth and cell division. Biochem. Biophys. Res. Commun. 292:333-338.
49. Peyril, A., Weitzdoerfer, R., Gulesserian, T., Fountoulakis, M., and Lubec, G. 2002. Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK 1 in fetal Down syndrome brain (trisomy 21). Electrophoresis 23:152-157.